TSPS SA Professional Services Requirement – Solutions Based
This requirement is for Health Canada
RFP #1000189262
Closing Date and Time: June 26, 2017 at 14:00 EDT
This requirement is open only to those Supply Arrangement Holders under E60ZT-16TSSB who qualified under Tier 1, Business Consulting/Change Management Stream – Business Analyst.
This requirement is open only to those invited TSPS Supply Arrangement Holders who qualified under the stream for: Change Management Consultant, Level 3.
The following SA Holders have been invited to submit a proposal.
Accenture Inc
ADGA Group Consultants Inc
BDO Canada LLP
CDCI Research
Deloitte Inc
Delsys Research Group Inc
Ernst & Young LLP
Goss Gilroy Inc
Groupe Intersol Group Ltee
Interis Consulting Inc
KORN FERRY HAY GROUP LTD./KORN FERRY HAY GROUP LTEE
KPMG LLP
Research Power Inc
RESEAU CIRCUM INC. / CIRCUM NETWORK INC.
TDV Global inc
Description of the requirement:
The Minister of Health announced the Canadian Drugs and Substances Strategy (CDSS); a comprehensive, collaborative, compassionate and evidence-based approach to drug policy. The Government is committed to ensuring that its policies under the CDSS are based on a strong foundation of evidence, including data related to morbidity, mortality and harm reduction policies, program and interventions. A strong evidence base enables the Government to better provide early warnings, identify trends, target interventions, monitor impacts and support decisions. While some aspects of Canadian drug surveillance and monitoring are well-developed, other key elements are missing to provide comprehensive, robust and timely data on, for example, drug-related deaths or use of new psychoactive substances and opioids. An enhanced monitoring and surveillance model is required to ensure a more systematic and sustained data collection effort in Canada. Internationally, other jurisdictions have adopted a reporting and analysis model generally referred to as a National Drugs Observatory (NDO) in response to reporting and policy development needs. The concept of a NDO is a best practice model for developing national level drug data collection on key aspects of drug use and harms, accompanied by data analysis and dissemination of information. While Health Canada and other organizations, federally and provincially/territorially, as well as regionally and locally currently perform some of these functions, Canada lacks a recognized central focal point that acts as a hub. While National Drugs Observatory (NDO) and Canadian Drugs Observatory (CDO) are both used in the current document, there exists a distinction between these two terms. Whereas NDO refers to the general concept of a drugs observatory and drugs observatories at large, the term CDO refers specifically to the Canadian Drugs Observatory and the functioning of a drugs observatory within the Canadian context. Health Canada is currently considering models for creating the CDO. To this end, Health Canada is contracting out a feasibility study and development of a business case.
Security Requirement:
There is no security required. Although unscreened contractors must be escorted by an employee or Commissionaire at all times when visiting GoC facilities.
Information which is to be used in the development of the contracted product, as reference material or otherwise made available to the contractor must be unclassified material and considered to be releasable to the public by HC/PHAC and/or The Government result of this contract of Canada. No Protected or Classified information is to be made available to the contractor, used in the production of the contracted product, or produced as a result of this contract.
Proposed period of contract:
The proposed period of contract shall be from Contract Award to the week ending September 15th, 2017.
File Number: 1000189262
Contracting Authority: Shari Rochon
E-Mail: s••••••••@•••••.••.ca
NOTE: The Task and Solutions Professional Services (TSPS) Method of Supply is subject to quarterly refresh cycles. If you wish to find out how you can be a “Qualified SA Holder”, please contact S••••••••@••••••••.••.CA
